These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6214144)

  • 41. Chemistry of bleomycin. VII. Synthesis of -amino- -(4-amino-6-carboxy-5-methylpyrimidin-2-yl)-propionic acid, an amine component of bleomycin.
    Yoshioka T; Muraoka Y; Takita T; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1972 Oct; 25(10):625-6. PubMed ID: 4119285
    [No Abstract]   [Full Text] [Related]  

  • 42. [Studies on tenuazonic acid analogs. III. Syntheses and antitumor activities of derivatives of tetramic acid, tetronic acid and thiotetronic acid, and others (author's transl)].
    Yuki H; Tsujimoto T; Sawada T; Takiura K; Yamaguchi T
    Yakugaku Zasshi; 1976 Apr; 96(4):536-43. PubMed ID: 945838
    [No Abstract]   [Full Text] [Related]  

  • 43. [Animal experimental studies on the biokinetics of astatide and astato-(I)-complex compounds].
    Wunderlich G; Henke E; Rösch F; Franke WG; Dreyer R
    Radiobiol Radiother (Berl); 1986; 27(4):387-92. PubMed ID: 3774992
    [No Abstract]   [Full Text] [Related]  

  • 44. [An electron-microscopic observation of tissue changes affected by anticancer agents. 2. Effects of bleomycin on the transplantable Vx-7 carcinoma of rabbits (author's transl)].
    Yamane G
    Shikwa Gakuho; 1974 Feb; 74(2):241-76. PubMed ID: 4136294
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of drugs on cholesterol metabolism in tumor-bearing mice.
    Kabara JJ; Chapman B; Borin B
    J Am Osteopath Assoc; 1969 Jun; 68(10):1035. PubMed ID: 5192761
    [No Abstract]   [Full Text] [Related]  

  • 46. Cobalt chelate of bleomycin. I. Physicochemical properties and distribution in tumor bearing mice.
    Kono A; Matsushima Y; Kojima M; Maeda T
    Chem Pharm Bull (Tokyo); 1977 Jul; 25(7):1725-31. PubMed ID: 71218
    [No Abstract]   [Full Text] [Related]  

  • 47. Biological studies on bleomycin A.
    Ichikawa T; Matsuda A; Miyamoto K; Tsubosaki M; Umezawa H
    J Antibiot (Tokyo); 1967 Jul; 20(3):149-55. PubMed ID: 6072795
    [No Abstract]   [Full Text] [Related]  

  • 48. [Studies on the calcium metabolism of tumor-bearing animals].
    Yasuda A
    Iryo; 1965 Dec; 19(12):1066-70. PubMed ID: 5884617
    [No Abstract]   [Full Text] [Related]  

  • 49. [Experimental studies on the affinity of flumejodin to tumor tissue].
    Matsuoka T; Saisho T; Kimura M; Konaka K
    Iryo; 1970 Nov; 24(11):893-7. PubMed ID: 5489006
    [No Abstract]   [Full Text] [Related]  

  • 50. [Enantiospecific synthesis of 4-O-benzyl derivative of 3-epishikimic acid from D-glucose].
    Sun KL; Ii RS; Lei XH
    Yao Xue Xue Bao; 1988 May; 23(5):343-6. PubMed ID: 3213514
    [No Abstract]   [Full Text] [Related]  

  • 51. Metabolites of alanosine, an antitumor antibiotic.
    Jayaram HN; Tyagi AK; Anandaraj S; Montgomery JA; Kelley JA; Kelley J; Adamson RH; Cooney DA
    Biochem Pharmacol; 1979 Dec; 28(24):3551-66. PubMed ID: 533558
    [No Abstract]   [Full Text] [Related]  

  • 52. The correlation of localization rates of benzeneboronic acids in brain and tumor tissue with substituent constants.
    Hansch C; Steward AR; Iwasa J
    Mol Pharmacol; 1965 Jul; 1(1):87-92. PubMed ID: 5835081
    [No Abstract]   [Full Text] [Related]  

  • 53. Unnatural amino acids: synthesis and biological significance.
    Cody WL; Hruby VJ
    Acta Univ Palacki Olomuc Fac Med; 1987; 116():495-516. PubMed ID: 2962463
    [No Abstract]   [Full Text] [Related]  

  • 54. [Determination of tissue scattering fraction and optimum adjustment of pulse height analyzer for the nuclide 99mTc (author's transl)].
    Ertl S
    Radiobiol Radiother (Berl); 1975; 16(6):745-53. PubMed ID: 1219867
    [No Abstract]   [Full Text] [Related]  

  • 55. Degradation and intracellular phosphorylation of showdomycin.
    Arendes J; Zahn RK; Hantke E; Müller WE
    Cancer Lett; 1978 May; 4(5):259-64. PubMed ID: 657123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Experimental cataract in vitro induced by antimetabolites (author's transl)].
    Mikuni I; Fujiwara T
    Nippon Ganka Gakkai Zasshi; 1978 Apr; 82(4):282-7. PubMed ID: 665456
    [No Abstract]   [Full Text] [Related]  

  • 57. [Method of determination of cumulative properties of drugs].
    Gol'dberg LE; Baumshteĭn VE
    Farmakol Toksikol; 1969; 32(2):222-6. PubMed ID: 5772152
    [No Abstract]   [Full Text] [Related]  

  • 58. [Bleomycin A derivative, 99mTc-BLAIDA: synthesis and distribution in tumor-bearing mice (author's transl)].
    Hu YL; Xie YY; Tao ZQ; Chen ZJ; Zhang JS; Ding GS
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):120-4. PubMed ID: 6214144
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis and quality control of 99mTc-p-butyl IDA.
    Zmbova B; Konstantinovska-Djokić D; Tadzer I
    Int J Appl Radiat Isot; 1985 May; 36(5):389-94. PubMed ID: 4018899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [ROTOP-BIDA for the preparation of 99mTc-Sn-N-(p-butylacetanilido)-iminodiacetate].
    Berger R; Syhre R; Abram U
    Radiobiol Radiother (Berl); 1986; 27(2):225-8. PubMed ID: 3714990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.